nystatin
Commercial- Indications
- Fungal infections
Company intelligence / Profile preview
Antibiotice Iași has a commercial-stage portfolio with over 160 generic medicines in 8 pharmaceutical forms across 11 therapeutic classes. The company leads globally in the production of Nystatin API and holds a strong position in anti-infective generics. It supplies essential medicines to hospitals and pharmacies domestically and exports to over 70 countries worldwide. The company operates modern GMP-certified manufacturing lines and an authorized Clinical Studies Center for Phase I/bioequivalence studies
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Antibiotice Iași.